JP2008512425A5 - - Google Patents

Download PDF

Info

Publication number
JP2008512425A5
JP2008512425A5 JP2007530680A JP2007530680A JP2008512425A5 JP 2008512425 A5 JP2008512425 A5 JP 2008512425A5 JP 2007530680 A JP2007530680 A JP 2007530680A JP 2007530680 A JP2007530680 A JP 2007530680A JP 2008512425 A5 JP2008512425 A5 JP 2008512425A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
gel
mixtures
alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007530680A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008512425A (ja
Filing date
Publication date
Priority claimed from EP04292170A external-priority patent/EP1634583A1/en
Application filed filed Critical
Publication of JP2008512425A publication Critical patent/JP2008512425A/ja
Publication of JP2008512425A5 publication Critical patent/JP2008512425A5/ja
Pending legal-status Critical Current

Links

JP2007530680A 2004-09-09 2005-09-07 透過促進剤としてのプロピレングリコールを含むテストステロンゲル Pending JP2008512425A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04292170A EP1634583A1 (en) 2004-09-09 2004-09-09 Testosterone gels comprising propylene glycol as penetration enhancer
US63836004P 2004-12-23 2004-12-23
PCT/EP2005/010293 WO2006027278A1 (en) 2004-09-09 2005-09-07 Testosterone gels comprising propylene glycol as penetration enhancer

Publications (2)

Publication Number Publication Date
JP2008512425A JP2008512425A (ja) 2008-04-24
JP2008512425A5 true JP2008512425A5 (enExample) 2008-10-02

Family

ID=39381985

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007530680A Pending JP2008512425A (ja) 2004-09-09 2005-09-07 透過促進剤としてのプロピレングリコールを含むテストステロンゲル

Country Status (6)

Country Link
JP (1) JP2008512425A (enExample)
BR (1) BRPI0515040B1 (enExample)
EA (1) EA013430B1 (enExample)
IL (1) IL181583A0 (enExample)
MX (1) MX2007002814A (enExample)
NZ (1) NZ553446A (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2147674A1 (en) * 2008-07-24 2010-01-27 Besins Healthcare Transdermal pharmaceutical compositions comprising danazol
CN107949389A (zh) * 2015-09-30 2018-04-20 富士胶片株式会社 经皮吸收用组合物
JP7220473B2 (ja) * 2017-10-30 2023-02-10 帝國製薬株式会社 経皮投与製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE107517T1 (de) * 1989-05-25 1994-07-15 Takeda Chemical Industries Ltd Transdermales therapeutisches mittel.
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
HRP20030510A2 (en) * 2000-12-22 2005-04-30 Dr. August Wolff Gmbh & Co. Arzneimittel Gel composition and trans-scrotal application of acomposition for the treatment of hypogonadism
EP1317921B1 (fr) * 2001-12-07 2009-08-19 Besins International Belgique Composition pharmaceutique sous forme de gel ou de solution à base de dihydrotestostérone, son procédé de préparation et ses utilisations
MY139721A (en) * 2002-04-19 2009-10-30 Cpex Pharmaceuticals Inc Pharmaceutical composition

Similar Documents

Publication Publication Date Title
US5900247A (en) Mucoadhesive pharmaceutical composition for the controlled release of active principles
TW576862B (en) Hydrophilic adhesive masses
ES2272586T3 (es) Preparacion con vehiculo farmaceutico aplicable a superficies de mucosas.
US6103266A (en) Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
JP2009528372A5 (enExample)
BRPI0618211B8 (pt) composição farmacêutica contendo pregabalina para dosagem uma vez ao dia e uso do referido composto
JP2005512995A5 (enExample)
JP2004504333A (ja) 抗真菌マニキュア組成物
AR042986A1 (es) Uso de una formulacion topica que comprende un agente dermatologico para la preparacion de un medicamento, composicion farmaceutica y un kit
CA2464578A1 (en) Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol and providing delayed release of the active ingredient
JP2010511663A5 (enExample)
WO2010103544A3 (en) A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants
TW201125567A (en) Composition and device for salicylic acid medication
CN1697656A (zh) 用于口腔粘膜的含有芬太尼的贴片
JP2012521351A5 (enExample)
BR0206441A (pt) Composição de revestimento de pelìcula, revestimento de pelìcula cobrindo um núcleo farmacêutico, formulação farmacêutica de liberação modificada, e, processos para preparar uma composição de revestimento de pelìcula, um revestimento de pelìcula e uma formulação
WO2004071374A3 (en) Once a day orally administered pharmaceutical compositions
ITMI20031640A1 (it) Base per gel bioadesivi.
RU2008147216A (ru) Жидкая лекарственная композиция
JP2004083462A5 (enExample)
US20090142389A1 (en) Hydrogel sheet and production method thereof
TR200601092T1 (tr) İrbesartan etkin maddesi içeren yeni oral farmasötik formülasyonlar.
TW201139605A (en) Hydrous adhesive patch
JPH0623094B2 (ja) 噴霧用ゲル基剤およびそれを用いたゲル剤
JP5059408B2 (ja) 爪用外用剤